StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health assumed Reinsurance Premiums Earned ($M)

Annual figures from Elevance Health's filings and investor materials

Latest, FY2025
5,100
Period ended Dec 31, 2025
Change on a year earlier
+7.3%
4,753 in FY2024
History
12 years
Since FY2014
Sources
2
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAssumed Reinsurance Premiums Earned ($M)Year on yearSource
FY2025Dec 31, 20255,100+7.3%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2024Dec 31, 20244,753-20.6%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2023Dec 31, 20235,988+8.8%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2022Dec 31, 20225,505+6.2%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2021Dec 31, 20215,182+54.4%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2020Dec 31, 20203,356+8.7%ELV 10-Q (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2019Dec 31, 20193,087+114.1%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2018Dec 31, 20181,442+424.4%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2017Dec 31, 2017275+26.7%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2016Dec 31, 2016217-2.3%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2015Dec 31, 2015222+14.4%ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗
FY2014Dec 31, 2014194–ELV 10-K (XBRL us-gaap:AssumedPremiumsEarned) ↗

Cite this data

StockData. (2026). Elevance Health Assumed Reinsurance Premiums Earned ($M), annual FY2014–FY2025 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/reins_assumed_premiums

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.